Best Breast biopsy doctors in Turkey: TOP 52 doctors

Content meets the Bookimed Editorial Policy and is medically reviewed by
Fahad Mawlood
Assoc Prof Guvenc Karlikaya Md
  • New
  • 34 years of experience
  • Turkey, Istanbul, Bahceci Fertility
  • Education

    •  1999-2000 OB/GYN residency at Newyork Medical College, NY, USA
    •  1993-1997 OB/GYN residency at Zeynep Kamil Maternity Hospital, Istanbul,Turkey
    •  1992-1993 OB/GYN residency at Zekai Tahir Burak Maternity Hospital, Ankara, Turkey
    • 1984-1991 Student at Istanbul University, Cerrahpasa Medical School, İstanbul, Turkey
    • 1981-1984 Student at Sisli Terakki High School, Istanbul, Turkey

    Work Experience

    •  2011- Bahceci Fulya ART center, İstanbul, Turkey
    •  2000-2011 ART&Genetics center at Istanbul Memorial Hospital, Istanbul, Turkey
    •  1997-1999 Reseach assistant at SUNNY at Brooklyn, NY, USA
    • 1991-1992 Emergency staff at Duzce Public Hospital, Duzce, Turkey

    Professional Interests

    • Ovarian stimulation protocols, preimplantation genetic diagnosis, fertility preservation techniques

    Memberships

    •  European Society of Human Reproduction & Embryology (ESHRE)
    •  American Society of Reproductive Medicine (ASRM)
    •  Turkish Society of Reproductive Medicine (TSRM)
    •  Turkish Obstetrics and Gynecology Society (TJOD)

    International Publications

    • • Kahraman S, Karagozoglu H, Karlikaya G. Reply of the Authors: Progesterone administration route in gonadotropin-releasing hormone antagonist cycles. (Letter to the Editor). Fertil Steril Vol. 94, No. 3, August 2010
    •  Banu Kumbak, Hande Akbas, Levent Sahin, Guvenc Karlikaya, Hale Karagozoglu, Semra Kahraman. Ovarian stimulation in women with high and low body mass index: GnRH agonist versus GnRH antagonist. Reproductive BioMedicine Online Mar; 20(3):314–319, 2010
    •  Semra Kahraman, Guvenc Karlikaya, Mustecep Kavrut, Hale Karagozoglu. A prospective, randomized, controlled study to compare two doses of recombinant human chorionic gonadotrophin in serum and follicular fluid in woman with high body mass index. Fertil Steril Vol. 93, No: 6, April 2010
    •  Semra Kahraman, S. Hale Karagozoglu, Guvenc Karlıkaya. The efficiency of progesterone vaginal gel v.s. intramuscular progesterone for luteal phase supplementation in GnRH antagonist cycles: A prospective, randomized clinical trial. Fertil Steril Vol.94, No.2, July 2010
    •  Y. Kumtepe, C. Beyazyurek, C. Cinar, I. Ozbey, S. Ozkan, K. Cetinkaya, G. Karlikaya, H. Karagozuglu, S. Kahraman. A genetic survey on severe male factor infertiliy in Turkish population. RBMOnline Vol.18 No: 4, 465 – 474, 2009
    •  Banu Kumbak, Semra Kahraman, Guvenc Karlikaya, Selman Lacin, Aysun Guney. In vitro Fertilization in Normoresponder Patients with Endometriomas: Comparison with Basal Simple Ovarian Cysts. Gynecologic and Obstetric Investigation, Vol. 65, No. 3, 2008: 212–216
    •  S Kahraman, N Findikli, G Karliklaya, S Sertyel, Y Saglam, H Karadayi, F Fiorentino. Medical and social perspectives of PGD for single gene disorders and human leukocyte antigen typing. Reproductive Biomedicine Online Volume 14, Suppl. 1, 104–108.
    •  S Kahraman, N Findikli, A Biricik, N Oncu, C Ogur, S Sertyel, G Karlikaya, H Karagozoglu, Y Saglam. Preliminary FISH studies on spermatozoa and embryos in patients with variable degrees of teratozoospermia and a history of poor prognosis. Reproductive Biomedicine Online. Volume 12, No 6.
    •  N Findikli, S Kahraman, Y Saglam, C Beyazyurek, S Sertye, G Karlikaya, H Karagozoglu, B Aygun. Symposium: Embryo implantation failure and recurrent miscarriage Embryo aneuploidy screening for repeated implantation failure and unexplained recurrent miscarriage. Reproductive Biomedicine Online Vol 13. No 1
    •  B Kumbak, E Oral, G Karlikaya, S Lacin, S Kahraman. Serum oestradiol and β-HCG measurements after day 3 or 5 embryo transfers in interpreting pregnancy outcome. Reproductive BioMedicine Online; Vol 13 No 4. 459–464.
    •  N Findikli, S Kahraman, Y Saglam, C Ogur, S Sertyel, G Karlikaya, H Karagozoglu, B Aygun. Embryo aneuploidy screening for repeated implantation failure and unexplained recurrent miscarriage Reproductive Biomedicine Online Vol 13. No 1. 2006 38–46.
    •  Fiorentino F, Kahraman S, Karadayi H, Biricik A, Sertyel S, Karlikaya G, Saglam Y, Podini D, Nuccitelli A, Baldi M. Short tandem repeats haplotyping of the HLA region in preimplantation HLA matching. European Journal of Human Genetics Vol: 13, Issue: 8, p.953–8.
    •  B Kumbak, E Oral, S Kahraman, G Karlikaya, H Karagozoglu. Young patients with diminished ovarian reserve undergoing assisted reproductive treatments: a preliminary report. Reproductive Biomedicine Online. Vol: 11, Issue: 3, p.294–299.
    •  S Kahraman, G Karlikaya, S Sertyel, H Karadayi, N Findikli, N Oncu. Clinical aspects of preimplantation genetic diagnosis for single gene disorders combined with HLA typing. Reproductive Biomedicine Online. Vol.: 9, Issue: 5, p.529-532.
    •  Fiorentino F., Biricik A., Karadayi H., Berkil H., Karlıkaya G., Sertyel S., Podini D., Baldi M., Magli MC., Gianaroli L. and Kahraman S. Development and clinical application of a strategy for preimplantation genetic diagnosis of single gene disorders combined with HLA matching. Molecular Human Reproduction Vol:10, Issue: 6, p.445 – 460.
    •  Kahraman S, Yakin K, Samli M, Vanlioglu F, Karlikaya G, Sertyel S, Donmez E A comparative study of three techniques for the analysis of sperm recovery: touch-print cytology, wet preparation, and testicular histopathology. Journal Assisted Reproduction Genetics Vol: 18, Issue: 7, p.357-363.
    •  Oktay K, Aydin BA, Karlikaya G. A technique for laparoscopic transplantation of frozen-banked ovarian tissue. Fertil Steril. 2001 Jun;75(6):1212-6. PubMed
    •  Oktay K, Karlikaya GG, Aydin BA. Ovarian cryopreservation and transplantation: basic aspects. Mol Cell Endocrinol. 2000 Nov 27;169(1-2):105-8. Review.
    •  Oktay K, Karlikaya G, Akman O, Ojakian GK, Oktay M. Interaction of extracellular matrix and activin-A in the initiation of follicle growth in the mouse ovary. Biol Reprod. 2000 Aug;63(2):457-61.
    •  Oktay K, Karlikaya G. Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med. 2000 Jun 22;342(25):1919.

    National publications

    •  Semra Kahraman, Güvenç Karlıkaya. Preimplantasyon Genetik Tanıda Güncel Durum. Klinik Aktüel Tıp Dergisi. Cilt: 1, Sayı: 1, sayfa 11 – 21.
    •  Semra Kahraman, Yaman Sağlam, Hüseyin Karadayı, Güvenç Karlıkaya. Bölüm: Talasemi ve Preimplantasyon Genetik Tanı. Talasemi ve Hemoglobinopatiler Tanı ve Tedavi. Duran Canatan, Yeşim Aydınok. Talasemi Federasyonu
    •  S. Kahraman, G. Karlıkaya, Y. Kumtepe, S. Sertyel, H. Karadayı, N. Fındıklı, E. Enginsu, N. Öncü, A. Biricik, F. Fiorentino. Tek gen hastalıklarında preimplantasyon genetik tanı ve HLA doku tiplemesi uygulamalarının klinik değerlendirmesi. Türk Fertilite Dergisi, Cilt: 12, Sayı:1, s.43–53.

    Book

    •  Semra Kahraman, Güvenç Karlıkaya. Ovülasyon İndüksiyonu, II. Basım, 2009.

    Book chapter

    • Semra Kahraman, Yaman Sağlam, Hüseyin Karadayı, Güvenç Karlıkaya. Bölüm:Talasemi ve Preimplantasyon Genetik Tanı. Talasemi ve Hemoglobinopatiler Tanı ve Tedavi. Duran Canatan, Yeşim Aydınok. Talasemi Federasyonu.

    International oral presentations

    • S. Kahraman, G. Karlikaya, M. Kavrut, H. Karagozoğlu. A prospective, randomized, controlled study to compare two doses of recombinant human chorionic gonadotrophin (rhCG) in women with high body mass index (BMI). ASRM 2009, Atlanta, Georgia, 17 – 21 October 2009
    •  G. Karlikaya, H. Karagozoglu, B. Kumbak, S. Lacin, A. Guney, S. Kahraman. Adding estradiol to progesteron for luteal phase support does not improve the clinical outcome in assisted reproductive technologies (ART) cycles. American Society for Reproductive Medicine. 62nd Annual Meeting New Orleans, LA, USA. October 21-25, 2006.
    •  S. Kahraman, O. Ozdiller, G. Karlikaya, S. Lacin, E. Ozturk Efficacy of metformin supplementation during ovarian stimulation in IVF patients with PCOS and BMI <28 kg/m2 American Society for Reproductive Medicine. 62nd Annual Meeting New Orleans, LA, USA October 21-25, 2006.
    •  G. Karlikaya, H. Karadayi, S. Sertyel, S. Saglam, B. Umay, S. Kahraman, F. Fiorentino. Comparison of the results of preimplantation genetic diagnosis for single gene disorders combined with or without HLA typing. 22nd Annual Meeting of the ESHRE, Prague, Czech Republic, 18–21 June 2006

    National oral presentations

    • G. Karlıkaya. ART başarısızlıklarında yönetim. Palandöken Kadın Doğum Kış Kongresi, Türk Jinekoloji ve Obstetrik Derneği, Erzurum 3-7 Mart 2010.
    • G. Karlıkaya. Embriyo seçimi için PGD – AS. TJOD İstanbul IVF Çalıştayı. Askeri Müze – Harbiye, İstanbul 15 Mart 2009
    •  G. Karlıkaya. PGD at Istanbul Memorial Hospital (2005-2008). 2nd hands-on workshop on PGD of Genetics&chromosomal disorders by blastomere and trophectoderm biopsy.İstanbul Memorial Hospital, İstanbul, Türkiye. 26-28 Şubat 2009
    •  G. Karlıkaya. Tek gen hastalıklarında preimplantasyon genetik tanı. 2. Ulusal Üreme Endokrinolojisi ve İnfertilite Kongresi (TSRM 2006). Antalya, Türkiye. 7–10 Eylül 2006.
    •  G. Karlıkaya. Ten gen hastalıklarında PGT. 5. Uluslar arası Talasemi Yaz Okulu. Belek, Antalya, Türkiye. 20-24 Nisan 2008
    •  G. Karlıkaya, S. Kahraman, H. Berkil, A. Biricik, H. Karagözoğlu, E. Dönmez, S. Sertyel, F. Vanlıoğlu, M. Aygün, S. Melil, M. Benkhalifa. Preimplantation genetic diagnosis results for the recurrent implantation failure cases with or without advanced maternal age. Fifth International Symposium on Preimplantation Genetics, Antalya, Turkey 5-7 June 2003.
    •  G. Karlıkaya, S. Kahraman, N. Fındıklı, E. Dönmez, A. Biricik, H. Berkil. Efficiency of aneuploidy testing in patients with recurrent implantation failure. Fifth International Symposium on Preimplantation Genetics, Antalya, Turkey 5-7 June 2003.

    Poster presentations

    •  N. Dokuzeylul, S. Kahraman, G. Karlikaya, H. Karagozoglu, M.Kavrut, A. Ersahin. Clinical Outcome of Women “37 Years with Hypogonadotropic Hypogonadism Undergoing Intracytoplasmic Sperm Injection and In-Vitro Fertilization. American Society for Reproductive Medicine 66th Annual Meeting 2010, 23-27 October, Denver, USA
    •  N. Dokuzeylul, S. Kahraman, G. Karlikaya, H. Karagozoglu, M. Kavrut, A. Ersahin. Clinical Outcome of Women ≤37 years with Hypogonadotropic Hypogonadism Undergoing Intracytoplasmic Sperm Injection and In-Vitro Fertilization. Vol. 94., No. 4, Supplement, September 2010
    •  G.Altin, S.Unal, H.Yelke, Y.Kumtepe, Z.Atayurt, S.Milik, C.Beyazyürek, C.Cınar, G.Karlikaya, S.Kahraman. Complete Or Partıal Correctıon Of Aneuploıdıc Embryos On Day 3 Formıng Hatchıng/Hatched Blastocysts on Day 5. 10th International Congress Preimplantation Genetic Diagnosis. May 5-8, 2010, Montpellier, France
    •  H. S. Karagozoglu, S. Kahraman, G. Karlikaya, M. Acet, N. Dokuzeylül, H. Yelke. Premature Luteinization Does Not Negatively Affect Pregnancy Outcome In High Responder Patients Undergoing Coastıng With Short Interval In IVF Cycles Treated With GNRH – Agonist Protocol. ASRM 2009, Atlanta, Georgia, 17 – 21 October 2009
    •  B. Kumbak, H. Akbas, L. Sahin, G. Karlikaya, H. Karagozoglu, S. Kahraman. Assisted Reproductive Treatment Outcome In a Large Cohort of Women With Serum FSH Above 15 Iu/L. ASRM 2009, Atlanta, Georgia, 17 – 21 October 2009
    •  B. Kumbak, H. Akbas, G. Karlikaya, H. Karagozoglu, L. Sahin, S. Kahraman. The Effect of a fall in the Serum Estradiol Level Prior to Egg Retrieval on the Outcome of Assisted Reproductive Treatment in Poor Responder Women. ASRM 2009, Atlanta, Georgia, 17 – 21 October 2009
    •  Akbas H, Kumbak B, Karlikaya G, Karagozoglu H, Sahin L, Kahraman S. Mikrodoz, uzun agonist veya antagonist protokolü verilen 40 yaş üstü kadınlarda yardımla üreme tedavi sonuçlarının karşılaştırılması. II. Üreme Tıbbı Derneği Kongresi, 1-4 Ekim 2009, Antalya.
    •  Kumbak B, Akbas H, Karlikaya G, Karagozoglu H, Sahin L, Kahraman S. Kadının over cevabının kötü olduğu TESE-ICSI sikluslarında yardımla üreme tedavisi sonuçları. II. Üreme Tıbbı Derneği Kongresi, 1-4 Ekim 2009, Antalya.
    •  Kumbak B, Akbas H, Karlikaya G, Karagozoglu H, Sahin L, Kahraman S. Antagonist protokolü ile yardımla üreme tedavisi uygulanan normal cevaplı kadınlarda serum estradiol/oosit oranının tedavi sonucuna etkisi. II. Üreme Tıbbı Derneği Kongresi, 1-4 Ekim 2009, Antalya.
    •  Akbas H, Kumbak B, Kahraman S, Sahin L, Karlikaya G, Karagozoglu H. Comparison of agonist long and antagonist protocols in women with BMI <18 kg/m2 undergoing assisted reproductive treatment. 8th Annual MSRM Meeting, 7-9 May, 2009, Florence, Italy. • Kumbak B, Kahraman S, Sahin L, Akbas H, Karlikaya G, Karagozoglu H. Comparison of agonist long and antagonist protocols in women with BMI >40 kg/m2 undergoing assisted reproductive treatment. 8th Annual MSRM Meeting, 7-9 May, 2009, Florence, Italy.
    •  Nur Dokuzeylül, Güvenç Karlıkaya, Gökhan Cumhur Ekmekçi, Hale Karagözoğlu, Çağrı Beyazyürek, Semra Kahraman. Sanfilippo Hastalığı Ve Preimplantasyon Genetik Tanı: Olgu Sunumu. 7. Ulusal Jinekoloji Ve Obstetrik Kongresi. TJOD 2009 14-19 Mayıs 2009, Girne, KKTC.
    •  H. Kargözoğlu, S. Kahraman, G. Karlıkaya, A. Erşahin, M. Kavrut, M. Acet. Premature Luteinzation does not negatively affect pregnancy outcome in high responder patients undergoing coasting with short interval in IVF cycles treated with Gnrh agonist protocol. 8.Türk Alman jinekoloji Kongresi 29 Nisan – 3 Mayıs 2009, Antalya
    •  N. Dokuzeylül, S. Kahraman, Güvenç Karlıkaya, Hale Karagözoğlu, Aynur Erşahin, Müstecep Kavrut, Mustafa Acet, Mete Gürol Uğur. Outcome of mild stimulation cycles in poor responders with short-term aplication of gnrh antagonist and low dose gonadotropins using clomiphene citrate. 15th World Congress on IVF, 19 – 22 Nisan 2009
    •  N. Dokuzeylül, S. Kahraman, Güvenç Karlıkaya, Hale Karagözoğlu, Aynur Erşahin, Müstecep Kavrut, Mustafa Acet, Mete Gürol Uğur. Luteal estradiol/gnrh antagonist suppression versus oral contraceptive pretreatment in young poor responders. 15th World Congress on IVF, 19 – 22 Nisan 2009
    •  Karlikaya G. Karagozoglu H., Beyazyurek C., Kahraman S. Preimplantation Genetic Diagnosis (PGD) Can Be A Valuable Tool For The Families With Thalassemia Trait. American Society for Reproductive Medicine’s 64th Annual Meeting, Bridge to the Future of Reproductive Medicine November 8 – 12, 2008, San Francisco, CA
    •  H. Karagözoğlu, G. Karlıkaya, Ç. Beyazyürek, F. Fiorentino, S. Kahraman. Clinical Outcomes Of 6 Year-Experience On HLA-Typing. American Society for Reproductive Medicine’s 64th Annual Meeting, Bridge to the Future of Reproductive Medicine November 8 – 12, 2008, San Francisco, CA
    •  Kavrut M., Karlikaya G., Karagozoglu H., Ersahin A., Acet M., Kahraman S. Predicting Factors For Endometrial Thickness And Its Effect On Assisted Reproductive Technology (Art) Success, Based On Analysis Of 1,552 IVF/ICSI Cycles. American Society for Reproductive Medicine’s 64th Annual Meeting, Bridge to the Future of Reproductive Medicine November 8 – 12, 2008, San Francisco, CA
    •  N. Dokuzeylul, G. Karlikaya, S. Kahraman. Which Is Your Favourite Protocol in Women ≥43 Years Old? Microdose Flare? Antagonist? Or No Way Out! American Society for Reproductive Medicine’s 64th Annual Meeting, Bridge to the Future of Reproductive Medicine November 8 – 12, 2008, San Francisco, CA
    •  Oner O, Ozgon G, Aslan C, Onal B, Fiorentino F, Karlikaya G, Kahraman S. The Results Of Missed Abortus Testing From Istanbul Memorial Hospital. European Society Of Human Genetics, Barcelona, Spain – May 31 – June 3, 2008
    • Aslan C, Ozgon G, Oner O, Onal B, Fiorentino F, Karlikaya G, Kahraman S. İstanbul Memorial Hastanesi 2000-2007 Yillari Arasinda Tahliye Materyali Karyotip Sonuçlari. 8. Ulusal Tıbbi Genetik Kongresi-Çanakkale, 6-9 Mayıs 2008.
    •  F.Vanlioglu, E.Ozturk, H.Karagozoglu, G.Karlikaya, A.Guney, S.Lacin, S.Kahraman. Adding GnRH antagonist in patient with elevated progesteron levels on day 3 of the cycle on the outcome of ongoing pregnancy rate. 23rd annual meeting of the European Society of Human Reproduction and Embryology, Lyon, France, 1-4 July 2007.
    •  H. Karadayi, Y. Saglam, B. Umay, G. Karlikaya, S. Sertyel, F. Fiorentino, S. Kahraman. Five year experience on preimplantation HLA typing. 23rd Annual Meeting of the ESHRE, Lyon, France, 1–4 July 2007
    •  Y. Saglam, C. Beyazyurek, S. Sertyel, G. Karlikaya, M. Yesil, S. Kahraman. Good, bad and ugly: effect of multiple indications on preimplantation genetics diagnosis. 23rd Annual Meeting of the ESHRE, Lyon, France, 1–4 July 2007
    •  F. Vanlioglu, G. Karlikaya, H. Karagozoglu, S. Lacin, A. Guney, E. Ozturk, S. Kahraman. Effect of heparin administration in moderate-severe ovarian hyperstimulation syndrome in PCOS patients undergoing controlled ovarian hyperstimulation. 23rd Annual Meeting of the ESHRE, Lyon, France, 1–4 July 2007
    •  E. Ozturk, H. Karagozoglu, F. Vanlioglu, G. Karlikaya, A. Guney, S. Lacin, S. Kahraman. Adding GnRH antagonist in patient with elevated progesteron levels on day 3 of the cycle on the outcome of ongoing pregnancy rates. 23rd Annual Meeting of the ESHRE, Lyon, France, 1–4 July 2007
    •  Y. Saglam, C. Beyazyurek, G. Karlikaya, H. Karagozoglu, S. Sertyel, S. Kahraman Outcome of 771 cycles of preimplantation genetic diagnosis for aneuploidy testing in IVF patients. 22nd Annual Meeting of the ESHRE, Prague, Czech Republic, 18–21 June 2006.
    •  F. Fiorentino, A. Biricik, H. Karadayi, H. Berkil, G. Karlikaya, S. Sertyel, D. Podini, M. Baldi, M.C.Magli, L. Gianaroli, S. Kahraman. Development and clinical application of a strategy for PGD of single gene disorders combined with HLA matching. 23rd Annual Meeting of the ESHRE, Lyon, France, 1–4 July 2007.
    •  B. Kumbak, S. Kahraman, G. Karlikaya, S. Lacin, A. Güney, E. Öztürk. Effect of endometrial thickness in the presence of triple-lined structure on the outcome of in vitro fertilization. American Society for Reproductive Medicine. 62nd Annual Meeting October 21-25, 2006. New Orleans, LA, USA.
    •  B. Kumbak, S. Kahraman, G. Karlikaya, S. Lacin, A. Güney. E. Öztürk. Effect of ovarian reserve at younger than 35 years age on ICSI outcome in couples with severe male infertility. American Society for Reproductive Medicine. 62nd Annual Meeting October 21-25, 2006. New Orleans, LA, USA.
    •  C. Ogur Beyazyurek, Y. Saglam, S. Sertyel, G. Karlikaya, S. Isin, S. Kahraman. Factors affecting outcome of preimplantation genetic diagnosis cycles for translocation cases. American Society for Reproductive Medicine. 62nd Annual Meeting October 21-25, 2006. New Orleans, LA, USA.
    •  C. Ogur, Y. Saglam, G. Karlikaya, A. Gur, S. Isin, S. Kahraman. Sperm fluorescence in situ hybridization analysis and preimplantation genetic diagnosis results of 13 male translocation carriers undergoing 17 cycles. 21st Annual Meeting of the European Society of Human Reproduction and Embryology, Copenhagen, Denmark 19-22 June 2005.
    •  F. Fiorentino, S. Kahraman, H. Karadayi, A. Biricik, S. Sertyel, G. Karlikaya, Y. Saglam, A. Nucitelli, M. Baldi. Experience on preimplantation genetic diagnosis combined with HLA matching. 21st Annual Meeting of the European Society of Human Reproduction and Embryology, Copenhagen, Denmark 19-22 June 2005.
    •  H. Karadayı, S. Kahraman, Yaman Sağlam, G. Karlıkaya, S. Sertyel, F. Fiorentino. Preimplantation Genetic Diagnosis for Single Gene Disorders. 13th World Congress on in-vitro Fertilization Assisted Reproduction & Genetics, Istanbul, Turkey, May 26-29, 2005.
    •  Saglam Y, Ogur C, Karlikaya G, Sertyel S, Karagozoglu H, Findikli N, Kahraman S. PGD of aneuploidy in difficult assisted reproductive treatment cases. Sixth International Symposium on Preimplantation Genetics 2005. London, UK. May 19–21, 2005.
    •  Sertyel S, Unal S, Yelke H, Atayurt Z, Findikli N, Karlikaya G, Fiorentino F, Kahraman S. The stage of the embryo but not the number of cells removed may affect embryo development after biopsy. Sixth International Symposium on Preimplantation Genetics 2005. London, UK. May 19–21, 2005.
    •  Findikli N, Kahraman S, Akcin O, Sertyel S, Candan Z, Karlikaya G, Fiorentino F. PGD for HLA typing can be a valuable source for the establishment of new human embryonic stem cell lines. Sixth International Symposium on Preimplantation Genetics 2005. London, UK. May 19–21, 2005.
    •  E. Enginsu, N. Findikli, S. Sertyel, S. Melil, Z. Atayurt, G. Karlikaya, F. Vanlioglu, S. Kahraman. Increasing hyaluronan concentrations in the embryo transfer medium has no effect on ART outcome. 20th Annual Meeting of the ESHRE, Berlin, Germany, 27–30 June 2004
    •  F. Fiorentino, A. Biricik, H. Karadayi, H. Berkil, G. Karlikaya, S. Sertyel, D. Podini, M. Baldi, M.C.Magli, L. Gianaroli, S. Kahraman. Development and clinical application of a strategy for PGD of single gene disorders combined with HLA matching. 20th Annual Meeting of the ESHRE, Berlin, Germany, 27–30 June 2004
    •  S. Kahraman, G. Karlikaya, S. Sertyel, F. Vanlioglu, H. Karadayi, N. Findikli, N. Oncu, A. Biricik, F. Fiorentino. Preimplantation Genetic Diagnosis for B-Thalassemia with or without HLA-typing. 20th Annual Meeting of the ESHRE, Berlin, Germany, 27–30 June 2004
    •  H. Yelke, S. Sertyel, E. Bakircioglu, N. Findikli, S. Unal, S. Melil, F. Vanlioglu, G. Karlikaya, S. Kahraman. Comparison using ejaculated or testicular sperm in patients with transient azospermia. 20th Annual Meeting of the ESHRE, Berlin, Germany, 27–30 June 2004
    •  H. Karagozoglu, F. Vanlioglu, G. Karlikaya, M. Aygun, B. Kumbak, S. Kahraman. Comparison of bipolar and unipolar electrosurgical system in operative hysteroscopy. 20th Annual Meeting of the ESHRE, Berlin, Germany, 27–30 June 2004
    •  H. Karadayı, S. Kahraman, G. Karlıkaya, S. Sertyel, B. Umay, Y. Sağlam, N. Fındıklı, H. Berkil, A. Biricik, F. Fiorentino. Wiscott Aldrich sendromu için preimplantasyon genetik tanı ve HLA doku tiplemesi uygulaması: Vaka sunumu. VI. Ulusal Prenatal Tanı ve Tıbbi Genetik Kongresi. 21–24 Nisan 2004, Belek, Antalya, Türkiye.
    •  S. Kahraman, H. Karadayı, G. Karlıkaya, S. Sertyel, Y. Sağlam, N. Fındıklı, H. Berkil, A. Biricik, F. Fiorentino. b-Talasemi için preimplantasyon genetik tanı ve HLA doku tiplemesi. VI. Ulusal Prenatal Tanı ve Tıbbi Genetik Kongresi. 21-24 Nisan 2004, Belek, Antalya, Türkiye.
    •  S. Kahraman, H. Karadayı, G. Karlıkaya, S. Sertyel, B. Umay, Y. Sağlam, E. Bakırcıoğlu, N. Öncü, H. Berkil, A. Biricik. Non-obstrüktif azoospermi hastalarında karyotip ve y kromozomu mikrodelesyon analizi sonuçları. VI. Ulusal Prenatal Tanı ve Tıbbi Genetik Kongresi. 21-24 Nisan 2004, Belek, Antalya, Türkiye.
    •  Faruk Vanlıoğlu, Semra Kahraman, Güvenç Karlıkaya, Hale Karagözoğlu, Melih Aygün, Banu Kumbak. Comparison of bipolar and unipolar electrosurgical system in operative hysteroscopy. 5 Mart 2004. Palandöken Kadın Doğum Kış kongresi, 3-7 Mart 2004, Erzurum, Türkiye.
    •  Berkil H., Biricik A., Oncu N., Findikli N., Donmez E., Sertyel S., Vanlıoğlu, Karlikaya G., Aygun M., Oral E. and Kahraman S. Results of Preimplantation Genetic Diagnosis (PGD) for Aneuploidy Testing in Cases with Advanced Maternal Age (AMA), Repeated Implantation Faulure (RIF), Recurrent Early Miscarriage and Severe Male Infertility (SMI). ESHRE Campus 2003. PGD in 2003: A Genetic Odyssey. 5-6 December 2003. Brussels, Belgium.
    •  Fiorentino F, Biricik A, Karadayi H, Berkil H, Karlikaya G, Sertyel S, Nucitelli A, Podini D, Baldi M, Magli MC, Gianaroli L and Kahraman S. Development and clinical application of a strategy for PGD of single gene disorders combined with HLA matching. ESHRE Campus 2003. PGD in 2003: A Genetic Odyssey. 5-6 December 2003. Brussels, Belgium.
    •  Melil S, Sertyel S, Bakircioglu E, Biricik A, Karlikaya G, Oncu N, Berkil H, Karagozoglu H, Vanlioglu F, Unal S, Yelke H, Findikli N and Kahraman S. Outcome of preimplantation genetic diagnosis in cases with severe sperm morphological defects. ESHRE Campus 2003. PGD in 2003: A Genetic Odyssey. 5-6 December 2003. Brussels, Belgium.
    •  Sertyel S, Bakircioglu E, Karlikaya G, Biricik A, Vanlioglu F, Findikli N, Oncu N, Gurkan S, Gur A, Berkil H, Oral E and Kahraman S. Results of preimplantation genetic diagnosis in patients with Klinefelter’s syndrome. ESHRE Campus 2003. PGD in 2003: A Genetic Odyssey. 5-6 December 2003. Brussels, Belgium.
    •  Faruk Vanlıoğlu, Semra Kahraman, Güvenç Karlıkaya, Hale Karagözoğlu, Mehil Aygün. Stromal over hasarı yapılan PCOS olgularının kontrollü ovulasyon indüksiyonuna verdiği yanıtın değerlendirilmesi. PCOS: Güncel durum, tedavi ve ovulasyon indüksiyonu, Uluslar arası Sempozyum. 4-7 Eylül 2003, Kemer, Antalya, Türkiye.
    •  Faruk Vanlıoğlu, Semra Kahraman, Güvenç Karlıkaya, Hale Karagözoğlu, Melih Aygün. Effect of metformin on subgroups of polycystic ovaries patients undergoing controlled ovarian hyperstimulation for assisted reproductive techniques. PCOS: Güncel durum, tedavi ve ovulasyon indüksiyonu, Uluslararası Sempozyum. 4-7 Eylül 2003, Kemer, Antalya, Türkiye.
    •  A. Biricik, H. Berkil, H. Karadayı, E. Bakırcıoğlu, S. Kahraman, F. Fiorentino, S. Sertyel, E. Dönmez, F. Vanlıoğlu, G. Karlıkaya. Molecular and cytogenetic analysis results in severe infertile males and their prognostic value for PGD in Turkish population. Fifth International Symposium on Preimplantation Genetics, 5-7 June 2003, Antalya, Turkey.
    •  N. Fındıklı, S. Kahraman, A. Biricik, E. Dönmez, S. Sertyel, S. Melil, F. Vanlıoğlu, G. Karlıkaya. Effect of zona manipulation on somatic cell nucleus transfer. Fifth International Symposium on Preimplantation Genetics, 5-7 June 2003, Antalya, Turkey.
    •  F. Vanlıoğlu, S. Kahraman, G. Karlıkaya, H. Karagözoğlu, M. Aygün. Effect on luteal support with vaginal micronized progesterone gel in assisted reproduction. V. Türk-Alman Jinekoloji Derneği ve II. Reproductive Medicine Tartışmalı Konular ve Çözümler Ortak Kongresi. 16-20.05.2003, Antalya, Türkiye.
    •  H. Berkil, A. Biricik, S. Kahraman, F. Vanlıoğlu, G. Karlıkaya, H. Karagözoğlu, M. Aygün, M. Benkhalifa. Tekrarlayan implantasyon başarısızlığı ve/veya ileri anne yaşı olgularında preimplantasyon genetik tanı sonuçları. Uluslararası Katılımlı Güncel İnfertilite ve Yardımcı Üreme Teknikleri Sempozyumu. 24-27 Nisan 2003, Çeşme, İzmir, Türkiye.
    •  Faruk Vanlıoğlu, Semra Kahraman, Güvenç Karlıkaya, Hale karagözoğlu, Melih Aygün. ART öncesi intra-uterin patoloji nedeniyle operatif histeroskopi yapılan olgularda kullanılan bipolar ve konvansiyonel unipolar elektrocerrahi tekniğinin karşılaştırılması. Uluslararası Katılımlı Güncel İnfertilite ve Yardımcı Üreme Teknikleri Sempozyumu. 24-27 Nisan 2003, Çeşme, İzmir, Türkiye.
    •  Biricik, H. Berkil, S. Kahraman, E. Dönmez, F. Vanlıoğlu, G. Karlıkaya, H. Karagözoğlu, M. Aygün, M. Benkhalifa. Yardımcı üreme teknikleri uygulanmış olan Türk populasyonunda preimplantasyon genetik tanı sonuçları. Uluslararası Katılımlı Güncel İnfertilite ve Yardımcı Üreme Teknikleri Sempozyumu. 24-27 Nisan 2003, Çeşme, İzmir, Türkiye.
    •  Kahraman S., Yakın K., Vanlıoğlu F., Dönmez E., Karlıkaya G., Kumtepe Y. Metformin as an adjuvant therapy in patients with polycystic ovaries undergoing controlled ovarian hyperstimulation. 18th Annual Meeting of the ESHRE. Vienna, Austria, 2002.
  • Read more
Doctor's visit
Price on request
Info
Sezer Saglam
  • New
  • 26 years of experience
  • Turkey, Istanbul, Gayrettepe Florence Nightingale Hospital
  • Personal Information 

    Sex:  Male

    Born : 1968 

     

    Professional Experience

    Gayrettepe Florence Nigthingale Hospital

    Medical Oncology Department

    Besiktas/Istanbul/Turkey (ongoing)

     

    Education:

    He became Professor (22/April /2016)

    Medical Oncology

     

    Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

    Istanbul University Oncology Institue,

    Department of Medical Oncology

     

    Medical Oncology Fellowship (December 2001-December2004)

    Istanbul University, Istanbul Medical Faculty

     

    Hemodialysis Traning (May1996-January1997)

    Istanbul University ,bCerrahpasa Medical Faculty

     

    Internal Medicine Residency (November 1991-November 1996)

    Istanbul University ,bCerrahpasa Medical Faculty

     

    Ege University Medical Faculty (1985-1991)

     

    Professional Experience

    February 1999-November 2001

    Metropolitan Florence Nigthingale Hospital

    American Cancer Center, Gayrettepe/İstanbul

     

    April1997- October 1998

    Bayraktar Dialysis Center

    Güngören/ Istanbul

     

    Membership

    Turkish Medical Oncology Association

    ENET(European Neuroendocrine Tumour Society)

    ESMO

    ASCO

  • Read more
Doctor's visit
Price on request
Info
Emine Yildirim
  • New
  • 28 years of experience
  • Turkey, Istanbul, Atlas University Medicine Hospital
  • 2023 – Istanbul Gaziosmanpaşa Taksim Education and Research Hospital – General Surgery Clinic Associate Professor

    2013 – Istanbul Gaziosmanpaşa Taksim Education and Research Hospital – General Surgery Clinic Specialist

    2008 – 2013 Private Medical Park Fatih Hospital, General Surgery Specialist - Deputy Chief Physician

    2005 – 2007 Private Gelişim Hospital – General Surgery Specialist

    2003 – 2005 Private Istanbul Şafak Hospital – General Surgery Specialist - Chief Physician

    2002 – 2003 ISTANBUL HASEKİ EDUCATION AND RESEARCH HOSPITAL – General Surgery Clinic Assistant Physician

    1998 – 2002 Ankara Education and Research Hospital – General Surgery Clinic Assistant Physician

    1998 – Health Sciences University – Istanbul Haseki Health Application and Research Center – Medical Specialization

    1991 – Gazi University Faculty of Medicine – Bachelor’s Degree

    Certificates

    IGM Diagnosis, Treatment Workshop, Granulomatous Mastitis, Kocaeli, Certificate, 07.10.2023 (National)

    ibreast 51- Free Flap Reconstruction, Breast Cancer Surgery, Online, Certificate, 30.09.2023 – 30.09.2023 (International)

    ibreast 50- Triple Negative Breast Cancer, Breast Cancer, Online, Certificate, 02.09.2023 -02.09.2023 (International)

    ibreast 49- Implant Based Reconstruction, Breast Cancer, Online, Certificate, 12.08.2023 -12.08.2023 (International)

    ibreast 48- DCIS, İbreast 48- DCIS, Online, Certificate, 15.07.2023 -15.07.2023 (International)

    ibreast 47- Conference Updates, Breast Cancer, Online, Certificate, 25.06.2023 -25.06.2023 (International)

    ibreast 46- Margin Revisited, Breast Cancer, Online, Certificate, 10.06.2023 -10.06.2023 (International)

    1. International 4. National Breast Surgery Congress, Breast Surgery, Ürgüp, Certificate, 05.05.2023 – 07.05.2023 (International)

    ibreast 44- HER2 Positive Disease, Breast Cancer, Online, Certificate, 29.04.2023 -29.04.2023 (International)

    St-Gallen 2023, St-Gallen Congress Summary Meeting, Istanbul, Certificate, 01.04.2023 -01.04.2023 (National)

    ibreast 43- Save The Nipple, Breast Cancer, Online, Certificate, 25.03.2023 -25.03.2023 (International)

    ibreast 42-Chest Wall Perforator Flap Revisited, Breast Cancer, Online, Certificate, 25.02.2023 -25.02.2023 (International)

    ibreast 41- High Risk And B3 Lesions, Breast Diseases, Online, Certificate, 28.01.2023 -28.01.2023 (International)

    15. New Approaches in Breast Cancer Education Meeting, Breast Cancer, Istanbul, Certificate, 07.01.2023 – 08.01.2023 (National)

    Articles she wrote and took part in;

    1.YILDIRIM EMİNE, BEKTAŞ SİBEL, YETİŞ FIRAT, YILDIZ EREN OZAN, ÖZDEMİR MUHAMMED, KOMUT NESLİHAN, ÇALIK MUSTAFA, ER AHMET MUZAFFER. Correlation between breast and axillary pathologic complete response after neoadjuvant chemotherapy in breast cancer. Annali Italiani di Chirurgia, 2023

    2.UZUN NEDİM, YILDIRIM EMİNE. Relationship Between Toilet Type and Hemorrhoids. Bezmialem Vakif University, 2022

    3.YILDIZ EREN OZAN, YILDIRIM EMİNE, ORHUN ERDOĞAN KIVILCIM, ERYILMAZ İKLİL, YÜNLÜEL EMİR MEHMET, YETİŞ FIRAT, ULUKENT SUAT CAN. The effect of the covid 19 pandemic on the number of patients treated for acute and complex acute appendicitis. Annali Italiani di Chirurgia, 2202

    4.YILDIRIM EMİNE, BEKTAŞ SİBEL, ÖZDEMİR MUHAMMED, KARAGÜLLE AHENK, ER AHMET MUZAFFER, UÇAR NEŞE. Upgrade Rates of DCIS, Intraductal Papilloma, and the Other High-risk Breast Lesions. Hamidiye Medical Journal, 2022
     

    5.ÖZKAN GÜMÜŞKAYA PERİHAN, ALTUN ÖZGÜR, KARAKÜTÜK YÜZTAŞ NUR, ÖZSOY NESLİHAN, AYDIN TUTAK GÜLTEN, YILDIRIM EMİNE, ADAŞ MİNE, KÜÇÜK MEHMET. COVID-19 Pnömonisi Sonrası AntiHBs Değerlerindeki Değişiklikler. Journal of Contemporary Medicine, 2022;12(4), 

    6.KOMUT NESLİHAN, BEKTAŞ SİBEL, YILDIRIM EMİNE. The relationship of tumor budding with GOLPH3 expression and histopathological prognostic parameters in colorectal adenocarcinoma. Annals of Diagnostic Pathology 2022 Jun;58:151933. 

    7.KAYADİBİ YASEMİN, UÇAR NEŞE, AKAN YEŞİM NAMDAR, KAYA MEHMET FATİH, YILDIRIM EMİNE, ALADAĞ KURT SEDA, SOYLU BOY FATMA NUR, TAŞKIN FÜSUN, İÇTEN GÜL ESEN. Magnetic resonance imaging findings associated with recurrence in idiopathic granulomatous mastitis. Clinical Imaging, 2022

    8.YILDIRIM EMİNE, KEĞİN MURAT, ÖZDEMİR MUHAMMED, BEKTAŞ SİBEL, PELEN ZEKERİYA, ER AHMET MUZAFFER. Neoplasms of theAppendix; Single Institution and Ten-Year Experiences Results. Turkish Journal of Trauma and Emergency Surgery, 2022;28(3), 352-360

    9.YILDIRIM EMİNE, YILDIZ EREN OZAN, ERYILMAZ İKLİL, ER AHMET MUZAFFER, BEKTAŞ SİBEL. Comparison of excised breast volume, re-excision rate and margin positivity in breast-conserving surgery in breast cancer patients using and not using neoadjuvant chemotherapy. Journal of Surgery in Medicine,2022;6

    10.YILDIRIM EMİNE, BEKTAŞ SİBEL, PELEN ZEKERİYA, YANIK İREM, ER AHMET MUZAFFER, ÇENGEL FERHAT, ÖZKAN GÜMÜŞKAYA PERİHAN. Histopathological, Radiological, and Demographic Factors Predicting the Response to Neoadjuvant Therapy for Rectal Cancer. Journal of Gastrointestinal Cancer, 2022;53(1)

    11.KAYADİBİ YASEMİN, KOÇAK BURAK, UÇAR NEŞE, AKAN YEŞİM NAMDAR, YILDIRIM EMİNE, BEKTAŞ SİBEL. MRI Radiomics of Breast Cancer: Machine Learning-Based Prediction of Lymphovascular Invasion Status. Academic Radiology, 2022;29(1), 126-134.

    12.YILDIRIM EMİNE, UÇAR NEŞE, YETİŞ FIRAT, KAYADİBİ YASEMİN, BEKTAŞ SİBEL. Diagnostic performance of breast imaging with ultrasonography, magnetic resonance and mammography in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients. Journal of Surgery and Medicine, 2022;6(1), 43-48

    13.YILDIRIM EMİNE, BEKTAŞ SİBEL, GÖKTAŞ AYDIN SABİN, ER AHMET MUZAFFER, YANIK İREM, ÖZKAN GÜMÜŞKAYA PERİHAN, YILMAZ BARBAROS UTKU, BİLİCİ AHMET, ÖNCEL MUSTAFA. Factors Predicting Response to Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer. Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi, 2022;85(1), 41-50. 

    14.YILDIRIM EMİNE, Pelen Zekeriya, KEĞİN MURAT, UÇAR NEŞE, KAYADİBİ YASEMİN, GÜNDOĞAR ÖZGECAN. Evaluation of the Reliability of Preoperative Ultrasonography and Ultrasonography-Guided Fine Needle Aspiration Biopsy in Axillary Staging in Patients With Breast Cancer. Journal of Academic Research in Medicine, 2021;11(3), 269-276., 

    15. KAYADİBİ YASEMİN, UÇAR NEŞE, KAYA MEHMET FATİH, YILDIRIM EMİNE, BEKTAŞ SİBEL. Characterization of Suspicious Microcalcifications on Mammography Using 2D Shear-Wave Elastography. Ultrasound in Medicine & Biology, 2022;47(9), 2532-2542. 

    16.KAYADİBİ YASEMİN, TEKCAN ŞANLI DENİZ ESİN, UÇAR NEŞE, YILDIRIM EMİNE, ŞANLI AHMET NECATİ. Evaluation of the Appearance Characteristics of Suspicious Microcalcifications Detected by Ultrasonography. Journal of Academic Research in Medicine, 2022;11(2), 199-205. 

    17.YILDIRIM EMİNE, ÖZER HİLAL, ÖZER İLTER, KOYUNCU ADİL, YILDIRIM TİMUR. The Effects on Bacterial Translocation and Tissue Damage of Selenium Treatment in an Experimental Intestinal Ischaemia-Reperfusion Model. Turkish Journal of Trauma and Emergency Surgery, 2021;27(4), 389-394. 

    18.YILDIRIM EMİNE, AKBAŞ PELİN, ORHUN ERDOĞAN KIVILCIM, BEKTAŞ SİBEL, ÖZKAN GÜMÜŞKAYA PERİHAN, ER AHMET MUZAFFER, PALTURA CEKİ. The comparison of the histopathological results of the thyroid fine-needle aspiration biopsies in the 795 patients with thyroidectomy. Diagnostic Cytopathology, 2021

  • Read more
Radiation therapy for brain tumor
$2,000 - $4,000
Breast cancer surgery
$7,853 - $8,725
Brain tumor removal
$10,906 - $14,178
Info
Yusuf Acikgoz
  • 4.5 Good 3 reviews
  • 9 years of experience
  • Turkey, Ankara, Lokman Hekim University Ankara Hospital
  • Associate Professor Dr. Yusuf AÇIKGÖZ
    Specialization: Medical Oncology

    Education:

    • 2004-2011: İnönü University Faculty of Medicine
    • 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
    • 2017-2022: Health Sciences University, Medical Oncology

    Professional Experience:

    • 2016-2017: Bingöl City Hospital, Internal Medicine
    • 2021-2022: Health Sciences University, Medical Oncology
    • 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
    • 2023-2024: Ohio State University, Medical Oncology
    • 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

    Clinical Trials, Courses, Certifications:

    Clinical Trials:

    • 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
    • 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

    Courses:

    • 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
    • 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
    • 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
    • 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
    • 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

    Certifications:

    • Ongoing: ECFMG Certification
    • 2024: CITI Responsible Conduct of Research (The Ohio State University)
    • 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
    • 2024: CITI Human Subjects Protection (The Ohio State University)
    • 2024: CITI Good Clinical Practice (The Ohio State University)
    • 2023: Occupational English Test (OET)
    • 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
    • 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
    • 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

    Memberships:

    • American Society of Clinical Oncology (ASCO) - 2022
    • Turkish Society of Medical Oncology - 2020
  • Read more
Doctor's visit
Price on request
Info
Senem Karabulut
  • New
  • 15 years of experience
  • Turkey, Istanbul, Biruni University Hospital
  • Education

    Istanbul University Cerrahpaşa Faculty of Medicine, 2002
    Istanbul Fatih Sultan Mehmet Training and Research Hospital, Internal Medicine, 2010
    Istanbul University Oncology Institute (Çapa), Medical Oncology, 2015
    Medipol University Faculty of Medicine, Phytotherapy Education, 2018
    University of Health Sciences, Vocational School of Health, Molecular Oncology, PhD Program, PhD, 2023

    Experience

    University Hospital, Newark, New Jersey, USA, Observer (2003-2004)
    Siirt State Hospital, Internal Medicine (2010-2011)
    Siirt State Hospital, Medical Oncology (2015)
    Bakırköy Dr. Sadi Konuk Training and Research Hospital, Medical Oncology (2015-2018)
    Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Medical Oncology, (Professor Doctor) (2018-Present)
    Forensic Medicine 3. Specialization Board, Medical Oncology, Full Member (2019-Present)
    Liv Hospital, Ulus, Park-time, Medical Oncology (2020-2022)
    Şişli Kolan International Hospital, Park-time, Medical Oncology (2022-2023)

     

    Medical Intrests

    • Gastrointestinal System Tumours (Esophagus - Stomach and Large Bowel Cancer)
    • Hepatobiliary System Tumours (Liver-Biliary Tract and Pancreatic Cancer)
    • Breast Cancer
    • Lung Cancer
    • Genitourinary Cancers
    • Immunotherapies and Target Therapies
    • Molecular Oncology
    • Immunotherapies
    • Target Treatments
    •  

    Awards

    2010-YDUS (Subspecialty Examination) 14th place in Turkey
    2014- Oncology Institute Days Best Poster Award
    2015- Turkish Medical Oncology Society Board Exam Qualification
    2015- ESMO (European Society for Medical Oncology) Board Exam Qualification

  • Read more
Complex treatment of thyroid cancer
$200 - $200
Info
Turkan Ozturk Topcu
  • New
  • 15 years of experience
  • Turkey, Istanbul, Biruni University Hospital
  • Education

    Cumhuriyet University Faculty of Medicine, 2004
    Istanbul Haydarpaşa Training and Research Hospital Internal Medicine Residency, 2010
    Karadeniz Technical University Faculty of Medicine Medical Oncology Residency, 2015

    Experience

    MD Andeson Cancer Center, USA, 2008
    Sunnybrook Odette Cancer Center Breast Cancer Clinic, Canada, 2017
    Moffit Cancer Center , USA 2022
    Istanbul Haydarpaşa Training and Research Hospital Internal Medicine, 2010
    İdil State Hospital Internal Medicine Clinic, 2011
    Karadeniz Technical Universityniversitesi Faculty of Medicine, Medical Oncology Clinic, 2015
    Istanbul Göztepe Training and Research Hospital, Medical Oncology Clinic, 2018
    Yeniyüzyıl University Gaziosmanpaşa Hospital, Medical Oncology Clinic, 2020
    Ataşehir Medicana Hospital, Medical Oncology Clinic, 2022

     

    Scientific Membership

    Turkish Medical Association (TTB)
    Turkish Society of Medical Oncology (TTOD)
    European Society for Medical Oncology (ESMO)
    American Society of Medical Oncology (ASCO)

     

    Medical Intrests

    • Breast Cancer
    • Lung Cancer
    • Colon Cancer
    • Stomach Cancer
    • Rectal Cancer
    • Ovarian Cancer
    • Liver Cancer
    • Oesophageal Cancer - Oesophageal Cancer
    • Kidney Cancer
    • Larynx Cancer - Cancer of the Larynx
    • Thyroid Cancer
    • Head and Neck Cancers
    • Gynaecological Cancers
    • Pancreatic Cancer
    • Oesophageal Cancer - Oesophageal Cancer
    • Uterine Cancer
    • Brain Cancers - Brain Tumours
    • Soft Tissue Cancer - Sarcomas
    • Prostate Cancer
    • Bladder Cancer
    • Bile Tract Cancer
    • Testicular Cancer
    • Cervical Cancer
    • Mouth, Tongue, Lip Cancers
    • Gastrointestinal System Cancers
    • Bone Tumours
    • Trachea and Bronchial Cancers
    • Skin Cancers - Skin Cancers
    • Skeletal System Tumours
    • Gallbladder Cancer
    • Mesothelioma
  • Read more
Complex treatment of thyroid cancer
$200 - $200
Info

Find out about the best doctors here

20 top ranked Breast biopsy doctors in the world are represented on this page. The list includes only verified specialists known for their experience and high success rates.

The ranking is composed according to the Bookimed patient reviews and considers the rating of hospitals where doctors practice.

Top 5 Breast biopsy doctors on Bookimed.com:

How to choose the best Breast biopsy doctors in the world?

The specialist’s CV contains details about the doctor’s expertise and work experience, education, scientific research, and languages spoken. Compare information on several specialists, read carefully about their experience, success rates, and methods they apply. Make sure the chosen doctor has relevant experience in the treatment of a medical issue you are looking for. Read reviews of patients who had a consultation with the chosen specialist.

Famous Breast biopsy doctors have vast experience, continue education constantly, participate in professional associations and have positive feedback from patients treated.

What is the cost of a doctor's consultation?

The price for the consultation on Breast biopsy varies between experts and depends on certain factors, such as:

  • the country of practicing
  • the clinical experience and reputation
  • the medical degree and educational background
  • the doctor’s workload
  • medical developments, proprietary techniques used, and awards, if any.

How to make an appointment with a chosen doctor?

To schedule your visit, just submit a request on Bookimed.com. Our coordinator will contact you to discuss the time and details of the appointment, so everything will go smoothly.

We can help to find the right doctors for Breast biopsy if you have any difficulties with a choice. Bookimed services are free for patients ♥

Where you go for medical treatment

Mustafa Solak-
  • New
  • 20 years of experience
  • Turkey, Istanbul, Hisar Hospital Intercontinental Comprehensive Cancer Center
  • Born in 1978, Specialist Dr. Mustafa Solak graduated from Hacettepe University Faculty of Medicine. He completed his residency at Istanbul Şişli Etfal Training and Research Hospital and received his Sub-specialty from Hacettepe University Cancer Institute.

    He has numerous cases related to Breast Cancer, Testicular Cancer, Ovarian Cancer, Lung Cancer, Head and Neck Cancers, and Gastrointestinal System Cancers.

    MEDICAL INTERESTS

    • Breast Cancer
    • Testicular Cancer
    • Ovarian Cancer
    • Lung Cancer
    • Head and Neck Cancers
    • Gastrointestinal System Cancers
  • Read more
Doctor's visit
Price on request
Info
Suleyman Alici-
  • New
  • 34 years of experience
  • Turkey, Istanbul, Hisar Hospital Intercontinental Comprehensive Cancer Center
  • Prof. Dr. Süleyman Alıcı completed his medical education at Atatürk University Faculty of Medicine. (1990) He later specialized in Internal Medicine between 1991-1995 at Selçuk University Faculty of Medicine Internal Medicine Clinic. He worked as an Assistant Professor at Yüzüncü Yıl University Faculty of Medicine Internal Medicine Clinic between 1996-1997. He obtained his subspecialty training in Medical Oncology at Istanbul University Faculty of Medicine (Çapa Medicine) between 1997-2000. After that, he worked again at Yüzüncü Yıl University Faculty of Medicine between 2000-2005 and established the Medical Oncology Department. He served as the head of the relevant department, providing training services to research assistant doctors and student education. He has supervised the theses of 2 research assistants in the internal medicine clinic. Alıcı, who received the title of Associate Professor in 2004, served as the clinical chief of the Medical Oncology Clinic at Ankara Atatürk Training and Research Hospital between 2005-2008. He was responsible for the formation and establishment of the Medical Oncology Clinic at the same hospital, providing training to Medical Oncology residents. In 2007, he received training and worked as an observer at Dana Farber Cancer Hospital and Massachusetts General Hospital in the fields of gastrointestinal tumors, breast cancer, and lung cancers (Thoracic Cancers).

    Prof. Dr. Süleyman Alıcı, who took part in the opening and establishment of Medicalpark Göztepe Oncology Hospital (2008-2017), worked at Acıbadem Hospital/Altunizade Branch in the Medical Oncology Clinic between 2017-2023.

    Alıcı has over 70 published articles in international peer-reviewed journals and over 50 scientific studies published in domestic peer-reviewed journals. He has presented over 100 papers at scientific meetings both domestically and internationally. In addition to his memberships in the European Society of Medical Oncology and the American Society of Clinical Oncology, he also has memberships in oncology associations within the country. He has received more than 10 scientific publication incentive awards from TÜBİTAK and some medical oncology associations.

    His areas of interest include gastrointestinal cancers such as Stomach-Intestine, Pancreatic cancers, as well as Lung Cancers.

    MEDICAL INTERESTS

    Stomach Cancer
    Intestinal Cancer
    Lung Cancer
    Ovarian Cancer
    Breast Cancer
    Esophageal Cancers

  • Read more
Doctor's visit
Price on request
Info
Ummugul Uyeturk-
  • New
  • 31 years of experience
  • Turkey, Istanbul, Hisar Hospital Intercontinental Comprehensive Cancer Center
  • Prof. Dr. Ümmügül Üyetürk completed her undergraduate and graduate education at Uludağ University Faculty of Medicine between 1988-1994. She specialized in Internal Medicine at Istanbul Training and Research Hospital from 1998 to 2003. Between 2008-2011, she received her subspecialty training in Medical Oncology at Ankara Oncology Training and Research Hospital.

    After serving as the deputy chief physician at Suluova State Hospital, she established the Internal Medicine Department and Medical Oncology Science Branch at Bolu Abant İzzet Baysal University between 2011-2020, where she served as the head of the science branch. During this time, she educated resident doctors and students. Üyetürk, who received the title of Associate Professor in 2014, spent 6 months in Canada/Toronto in 2019. In 2020, she was awarded the title of Professor at Abant İzzet Baysal University.

    Üyetürk has published over 60 articles in international peer-reviewed journals and has more than 20 scientific works published in national peer-reviewed journals. She also has over 100 presentations that have been delivered at international and national scientific meetings and published in proceedings books. In addition to her membership in the European Society for Medical Oncology, she has memberships in medical oncology associations within the country. She has received more than 10 awards given to her at universities and congresses.

    MEDICAL INTERESTS

    • Prostate Cancer and Urological Cancers
    • Lung Cancer
    • Gastrointestinal System Cancers
    • Breast Cancer
    • Ovarian, Endometrial, and Cervical Cancers (Genital Cancers)
  • Read more
Doctor's visit
Price on request
Info
Hasan Mutlu
  • 3 Good 1 review
  • 26 years of experience
  • Turkey, Antalya , Medical Park Antalya Hospital Complex
  • Education and Specialization

    • Faculty of Medicine, Hacettepe University
    • 1999 - Akdeniz University, Faculty of Internal Medicine, Internal Medicine Specialization Training
    • Internal Medicine Specialization Training in the USA, Akdeniz University (2013 - 2014)
    • Internal Medicine Specialization Training in the USA (2013 - 2014) - Medical Oncology Department
    • Akdeniz University, Faculty of Medicine, Department of Medical Oncology (Received Associate Professorship title)

    Work Experience

    • 2009 - Kayseri Training and Research Hospital, Hospital
    • Acıbadem Kayseri
    • 2017 - 2018 - Lara Private Anadolu Hospital
    • 2018 - Medical Park Antalya Hospital Complex

    Expertise

    • Diagnosis of organ tumors
    • Chemotherapy in cancer treatment
    • Targeted cancer therapies
    • Immunotherapy in cancer treatment
    • Next-generation genetic research in cancer treatment
    • Complementary medicine in cancer treatment
    • Medical oncology
  • Read more
Hormone therapy
$1,100 - $1,100
Allogenic bone marrow transplantation from a related donor
$6,000 - $15,000
Targeted therapy
$750 - $2,500
Info
Mustafa Serkan Alemdar
  • 3 Good 1 review
  • 19 years of experience
  • Turkey, Antalya , Medical Park Antalya Hospital Complex
  • Education and Specialization

    • 2006: Kocaeli University Faculty of Medicine
    • 2014: Akdeniz University Faculty of Medicine, Internal Medicine
    • 2018: Akdeniz University Faculty of Medicine, Medical Oncology

    Experience

    • 2006 - 2008: Konya Derebucak District Hospital
    • 2009 - 2015: Akdeniz University Hospital
    • 2015: Antalya Kaş State Hospital
    • 2015 - 2016: İnönü University Faculty of Medicine
    • 2016 - 2021: Akdeniz University Hospital
    • 2021 - 2023: Antalya Training and Research Hospital
  • Read more
Hormone therapy
$1,100 - $1,100
Allogenic bone marrow transplantation from a related donor
$6,000 - $15,000
Targeted therapy
$750 - $2,500
Info
Choosing Right Doctor and Clinic: Insider Tips
When selecting a doctor or clinic, keep these key points in mind:
Check credentials
Verify certifications from bodies like ISAPS, JCI, etc.
Review success rates
Choose doctors with solid experience in your specific treatment.
Read patient reviews
Browse Bookimed reviews from real patients to learn about their experiences.
Ensure effective communication
Pick clinics that offer language support for a smooth treatment process.
Ask about services
Confirm if they provide accommodation and transfers, and check the costs.
Choosing a clinic abroad can be stressful. At Bookimed, with over 800K patients helped, we understand your concerns. We know how to find trusted doctors, the best price-quality options, and solutions for even complex cases. We’re here to guide you every step of the way.
Yan Matsiivskiy
Head of Medical Coordinator Team